US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT07927413 N/A
Recruiting
Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural ...
Condition
Cerebrospinal Fluid (CSF) Leak
Enrollment
600 pts
Location
United States
Sponsor
Corza Medical GmbH
View Trial →
NCT05667142 Phase 3
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-C...
Condition
Primary Generalized Tonic-Clonic Seizures
Enrollment
160 pts
Location
United States, Argentina, Australia
Sponsor
Xenon Pharmaceuticals Inc.
View Trial →
NCT06512883 Phase 3
Recruiting
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
Condition
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Enrollment
14 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
View Trial →
NCT07867080 Phase 3
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Mac...
Condition
Diabetic Macular Edema (DME)
Enrollment
514 pts
Location
United States, China, Japan
Sponsor
4D Molecular Therapeutics
View Trial →
NCT02432560 N/A
Recruiting
Safety and Durability of Sirolimus for Treatment of LAM
Condition
Lymphangioleiomyomatosis
Enrollment
600 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT05993546 N/A
Recruiting
Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Va...
Condition
Kidney Stone
Enrollment
90 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT06960213 Phase 3
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Condition
Hereditary Angioedema
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
ADARx Pharmaceuticals, Inc.
View Trial →
NCT00567073 N/A
Recruiting
Pompe Pregnancy Sub-Registry
Condition
Glycogen Storage Disease Type II (GSD-II)
Enrollment
20 pts
Location
United States, Australia, Belgium
Sponsor
Genzyme, a Sanofi Company
View Trial →
NCT03999983 N/A
Recruiting
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
Condition
Vertebral Artery Stenosis
Enrollment
150 pts
Location
United States
Sponsor
St. Louis University
View Trial →
NCT06049680 Phase 4
Recruiting
Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in...
Condition
Malnutrition, Child
Enrollment
100 pts
Location
United States
Sponsor
Fresenius Kabi
View Trial →
NCT06328608 Phase 2, Phase 3
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Child...
Condition
Fabry Disease
Enrollment
22 pts
Location
United States, Austria, France
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
NCT07699991 N/A
Recruiting
A Navigation Program to Improve Survivorship Support Service Participation Among...
Condition
Anatomic Stage 0 Breast Cancer AJCC v8
Enrollment
330 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT07243652 N/A
Recruiting
I-DECIDE After Bronchiolitis Hospitalization
Condition
Bronchiolitis Acute
Enrollment
2,700 pts
Location
United States, Canada
Sponsor
Seattle Children's Hospital
View Trial →
NCT07723248 Phase 3
Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Pati...
Condition
Metastatic Castration Resistant Prostate Cancer
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
ORIC Pharmaceuticals
View Trial →
NCT05806515 Phase 2
Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cance...
Condition
Prostate Adenocarcinoma
Enrollment
44 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04561518 N/A
Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-M...
Condition
Transthyretin-Mediated Amyloidosis
Enrollment
1,500 pts
Location
United States, Brazil, Bulgaria
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT06450925 Phase 2
Recruiting
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Condition
Graft Vs Host Disease
Enrollment
190 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05210374 Phase 1
Recruiting
Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refracto...
Condition
Relapsed Sarcomas
Enrollment
24 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent
View Trial →
NCT07428538 Phase 3
Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With ...
Condition
Hepatitis
Enrollment
350 pts
Location
United States
Sponsor
Bausch Health Americas, Inc.
View Trial →
NCT07219589 Phase 1
Recruiting
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Parti...
Condition
Obesity
Enrollment
90 pts
Location
United States
Sponsor
Hanmi Pharmaceutical Company L
View Trial →
NCT07221474 Phase 2
Recruiting
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy i...
Condition
Squamous Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04126018 N/A
Recruiting
Comparative Imaging Assessment of Valvular Heart Disease
Condition
Valve Heart Disease
Enrollment
200 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT07586618 Phase 1
Recruiting
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Har...
Condition
Lymphoblastic Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Allterum Therapeutics, Inc
View Trial →
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT05314608 N/A
Recruiting
Knee Related Subchondral Bone Lesions Treated With IOBP
Condition
Subchondral Cyst
Enrollment
100 pts
Location
United States
Sponsor
Arthrex, Inc.
View Trial →
Page 14 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology